# Visiogen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/visiogen

- Industry: Healthcare Specialists
- Headquarters: Irvine, US
- Website: www.visiogen.com
- Total disclosed funding: $24M
- Latest round: Series D (Feb 28, 2007)
- Investors on record: 7

## About

Visiogen is a company specializing in domain name sales, providing essential digital assets for businesses and individuals looking to establish their online presence. It offers the domain name 'Visiogen.com' for purchase or lease.Founded in 2001 and headquartered in Irvine, California, US, Visiogen specializes in the sale of the domain name 'Visiogen.com'. The company has undergone no notable pivots in its strategy and does not have subsidiaries. Visiogen has completed 4 deals, with the most recent being a Trade Sale on September 2, 2009, where it raised USD 400.00 mn from Abbott Laboratories. This total amount raised matches the latest round funding, indicating a substantial investment.Visiogen.com is primarily focused on domain sales, offering the domain name 'Visiogen.com' for purchase at a price point of USD 9,295 or through a monthly payment plan of USD 387.29 for 24 months. The company caters to a diverse clientele, including entrepreneurs and businesses, who seek to establish an online presence. Its core offering is pivotal for brand identity in the digital marketplace, providing customers with a straightforward purchasing process that allows for quick acquisition of domain ownership, typically within one to two hours after completing the transaction. Visiogen.com serves customers mainly in the United States and internationally, enabling users to manage their domain through NameBright.com, the company’s registrar partner.The revenue model for Visiogen.com revolves around the direct sales of domain names, featuring pricing options for immediate purchase or installment payments. Customers can choose a one-time payment or a structured payment plan, accommodating various needs from individual users to businesses seeking a memorable domain name. The purchase includes a 30-day money-back guarantee, which enhances customer confidence. While specific revenue figures are not disclosed, the pricing strategy and customer engagement suggest a B2C business model focused on direct sales of digital assets.Visiogen has not publicly disclosed any upcoming products or significant strategies for expansion into new markets or geographic regions. The most recent funding round will likely be utilized to support ongoing operations and strengthen its domain sales focus. The company remains committed to facilitating access to its services globally, leveraging partnerships such as that with NameBright.com.

## Funding rounds

- Series D, Feb 28, 2007, $24M — Prospect Venture Partners, Technology Partners, Foundation Medical Partners, Three Arch Partners, Novartis Venture Fund, Presidio Partners, New Leaf Venture Partners

## Investors

- Prospect Venture Partners (https://capitalatlas.ai/funds/prospect-venture-partners) — Series D
- Technology Partners — Series D
- Foundation Medical Partners (https://capitalatlas.ai/funds/foundation-medical-partners) — Series D
- Three Arch Partners (https://capitalatlas.ai/funds/three-arch-partners) — Series D
- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series D
- Presidio Partners (https://capitalatlas.ai/funds/presidio-partners) — Series D
- New Leaf Venture Partners (https://capitalatlas.ai/funds/new-leaf-venture-partners) — Series D